Tria Beauty, Inc. announces the closing of $45.5 million in new equity financing and a new structured debt facility. This latest round of equity financing was led by Bay City Capital, and joined by new investors, AmorePacific Ventures and Athyrium Capital Management. All major existing investors including Aisling Capital, DeNovo Ventures, Morgan Stanley Alternative Investment Partners, Vivo Ventures and Technology Partners all participated in the equity financing. These funds will be used to launch multiple new laser devices for skin care, including the company’s first device in the largest skin care segment – anti-aging. Want to read more? Subscribe to one of our monthly plans to continue reading this article.